In September 2017, United States Agency for International Development (USAID) awarded a five-year Health Safe, Affordable, and Effective Medicines (SAFEMed) contract to Management Sciences for Health (MSH).
SAFEMed applies health system-strengthening best practices to create evidence-based interventions and strengthen Ukraine's pharmaceutical system in line with the Ministry of Health's (MOH) health care reform objectives.
SAFEMed seeks to improve access to appropriate, quality medicines to maximize availability within MOH's budgetary constraints.
SAFEMed interventions will institutionalize rational medicine selection, strengthen and systematize public procurement of pharmaceuticals and commodities, support sustainable public sector pharmaceutical financing, and strengthen the pharmaceutical supply chain in collaboration with the Government of Ukraine (GOU), the MOH and the National Health Service of Ukraine (NHSU), civil society partners, other implementing partners, and the private sector.
By the end of SAFEMed, Ukraine's pharmaceutical system will be more transparent and cost efficient, and availability of medicines will increase, thereby supporting the GOU goal of a health care system that produces desired health outcomes.
In pursuit of its goal, SAFEMed has three primary project objectives :
Providing technical support to the Government of Ukraine in health policy priority-setting is a key focus for SAFEMed and encompasses the development of HTA capability in Ukraine, along with the governance and institutional structures required to operationalize the concept.
SAFEMed supports the MOH and the HTA department to make sure that HTA is seen and used as the key tool for decision-making with respect to health technology access in Ukraine.
HTA is a tool that can be used not only by the Ministry of Health. It can support identification of medicines, vaccines, and other technologies to be used by National Health Services of Ukraine (NHSU), Public Health Center (CPH), and Medical Central Procurement Agency (CPA) with public funds.
In 2017, the Ukrainian MOH created a state medicines reimbursement program known as the Affordable Medicines Program. Over the past two years, USAID's SAFEMed supported the transition of the Affordable Medicines Program to the newly established NHSU.
Moving forward, SAFEMed will continue providing technical support, as well as capacity-building efforts, to the NHSU to make sure that the newly established government entity is fully prepared to manage the program independently at scale.
SAFEMed will also support NHSU to strategically expand the Affordable Medicines program in 2021 using epidemiological and market-
based data, allowing for more Ukrainians to receive the medicines they require at low or no cost.
Based in Kyiv, Ukraine, the overall purpose of this position is to support the SAFEMed activities that improve access to medicines and other technologies guided by HTA and evidence-
based medicine, under the guidance and oversight of SAFEMed Senior Technical Advisor.
Day-to-day duties may include but are not limited to the following tasks :
Qualifications and Experience
Education : Required :
Knowledge and Skills : Required :
Management Sciences for Health (MSH), a global health nonprofit organization, uses proven approaches developed over 40 years to help leaders, health managers, and communities in developing nations build stronger health systems for greater health impact.
We work to save lives by closing the gap between knowledge and action in public health. Since its founding in 1971, MSH has worked in over 150 countries with policy makers, health professionals, and health care consumers to improve the quality, availability and affordability of health services.
tuberculosis; malaria; maternal, newborn and child health; family planning and reproductive health; and chronic non-communicable diseases such as cancer, diabetes, and lung and heart disease.
Through strengthening capacity, investing in health systems innovation, building the evidence base, and advocating for sound public health policy, MSH is committed to making a lasting difference in global health.